Drugs / ICG-99mTc-nanoscan
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06666634 | Apr 2023 → Aug 2025 overdue | melanoma, oral cavity cancer, penile cancer | The Netherlands Cancer Institute | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ICG-99mTc-nanoscan | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06666634 ↗ |